Teva is undertaking a $1bn expansion programme in India. Initially, the company plans to use $250m-$300m to build new generic ingredients manufacturing facilities. The first of these is a large API manufacturing facility Gwalior, Madhya Pradesh.
In-Pharma Technologist
Thursday, 10 January 2008
Teva invests
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment